In preclinical investigations, inhibition of MMP9 reduced disease severity in a mouse model of ulcerative colitis, and decreased tumor growth and metastasis in a surgical orthotopic xenograft model of colorectal carcinoma. The gene discussed is MMP9; the disease is neoplasm.